About Beijing Xinyi Biotechnology
Beijing Xinyi Biotechnology is a company based in Haidian (China) founded in 2015 by Wenjun Yang.. Beijing Xinyi Biotechnology has raised $23.19 million across 3 funding rounds from investors including Jiuzhi Capital, Lilly Asia Ventures and China Growth Capital. Beijing Xinyi Biotechnology operates in a competitive market with competitors including NeuMoDx, GenMark Diagnostics, Biomeme, Sense Biodetection and Kryptos Biotechnologies, among others.
- Headquarter Haidian, China
- Founders Wenjun Yang
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$23.19 M (USD)
in 3 rounds
-
Latest Funding Round
-
Investors
Jiuzhi Capital
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Beijing Xinyi Biotechnology
Beijing Xinyi Biotechnology has successfully raised a total of $23.19M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Last Round
- First Round First Round
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2024 | Amount | Series B - Beijing Xinyi Biotechnology | Valuation | Jiuzhi Capital |
|
| Jan, 2021 | Amount | Series B - Beijing Xinyi Biotechnology | Valuation | Lilly Asia Ventures , China Growth Capital |
|
| Sep, 2018 | Amount | Seed - Beijing Xinyi Biotechnology | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Beijing Xinyi Biotechnology
Beijing Xinyi Biotechnology has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Jiuzhi Capital, Lilly Asia Ventures and China Growth Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Global private equity investments are managed with long-term focus.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Beijing Xinyi Biotechnology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Beijing Xinyi Biotechnology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Beijing Xinyi Biotechnology Comparisons
Competitors of Beijing Xinyi Biotechnology
Beijing Xinyi Biotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NeuMoDx, GenMark Diagnostics, Biomeme, Sense Biodetection and Kryptos Biotechnologies, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of a platform for low cost molecular testing
|
|
| domain | founded_year | HQ Location |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
|
| domain | founded_year | HQ Location |
Smartphone-based DNA detection platform is developed for diagnostics.
|
|
| domain | founded_year | HQ Location |
Provider of point of care molecular diagnostics solutions
|
|
| domain | founded_year | HQ Location |
Point-of-care molecular diagnostics are enabled by Ultrafast Photonic PCR technology.
|
|
| domain | founded_year | HQ Location |
Provide tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Beijing Xinyi Biotechnology
Frequently Asked Questions about Beijing Xinyi Biotechnology
When was Beijing Xinyi Biotechnology founded?
Beijing Xinyi Biotechnology was founded in 2015 and raised its 1st funding round 3 years after it was founded.
Where is Beijing Xinyi Biotechnology located?
Beijing Xinyi Biotechnology is headquartered in Haidian, China. It is registered at Haidian, Beijing, China.
Is Beijing Xinyi Biotechnology a funded company?
Beijing Xinyi Biotechnology is a funded company, having raised a total of $23.19M across 3 funding rounds to date.
What does Beijing Xinyi Biotechnology do?
Beijing Xinyi Biotechnology was founded in 2015 and is based in Haidian, China. Operations focus on the biotechnology sector, where micro-droplet digital PCR systems and in vitro diagnostic reagents are produced. Key products encompass drop makers for sample preparation, chip readers, universal PCR amplification reagents, genetic testing kits for research purposes, micro-droplet detection oil, and nucleic acid extraction reagents using magnetic beads. The domain targetingone.com is associated with the company.
Who are the top competitors of Beijing Xinyi Biotechnology?
Beijing Xinyi Biotechnology's top competitors include GenMark Diagnostics, NeuMoDx and Altratech.
Who are Beijing Xinyi Biotechnology's investors?
Beijing Xinyi Biotechnology has 5 investors. Key investors include Jiuzhi Capital, Lilly Asia Ventures, China Growth Capital, Hillhouse, and Huade Capital Management Group.